We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference. Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.
Abbott is a global healthcare leader that helps people live life to the full. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.
At Abbott, we believe people with diabetes should enjoy active lives, so we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor their glucose and provides healthcare professionals with more data to make more informed treatment decisions.
© 2026 Abbott. ADC-129168 03/26 v1.0
Website: Home | Healthcare Professionals | FreeStyle | Abbott
Lilly is a medicine company turning science into therapies to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world’s most significant health challenges.
We have been a global leader in diabetes since 1923, and are redefining diabetes and obesity care today. Through research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity.
To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/.
With nearly 50 years of experience, Roche is dedicated to helping people with diabetes think less about their daily routines so they can experience true relief, day and night. Through our Accu-Chek® and mySugr® brands, we offer an integrated ecosystem of solutions, from traditional blood glucose monitoring to predictive continuous glucose monitoring (CGM) technology and digital data management, supporting people with diabetes and healthcare providers, no matter where they are on their diabetes journey.
Learn more: accu-chek.co.uk/hcp
AgaMatrix Europe Limited, based in Oxfordshire, is a specialised diabetes monitoring company. Three core values drive our product development: Accuracy, features and value. ALLYbgk is our latest innovation in blood glucose monitoring, providing both glucose and β-ketone testing to the NHS for exceptional value for money. ALLYcgm is our continuous glucose monitor which provides the accuracy you need, the features you want and better value to the patient and the NHS. Our A1Care HbA1c analyser is known for its cost effective, simple and fast point of care testing capability. Diabetes monitoring is our purpose, and our people are passionate about making a difference to the lives of those managing this condition. Come and visit our stand to find out more about our recent listings on Part IX of the Drug Tariff for ALLYbgk and ALLYcgm.
Learn more: www.agamatrix.co.uk or www.allycgm.co.uk
Ascensia Diabetes Care is committed to empowering people with diabetes by delivering smart, innovative solutions that simplify daily management and enhance quality of life.
The CONTOUR®PLUS BLUE meter and strips offer high accuracy and feature Second‑Chance® sampling, allowing users to add more blood to the same strip within 30 seconds. This helps reduce wasted strips and minimises frustration. The smartCOLOUR™ target range indicator provides clear, easy‑to‑understand feedback to support confident self‑monitoring.
As a trusted partner in the diabetes community, we work closely with healthcare professionals to ensure our products meet the highest standards of accuracy, precision, and reliability.
Learn more here: https://www.diabetes.ascensia.co.uk/
At Dexcom, we believe that with Diabetes, knowledge is power. We’ve spent the last 20 years innovating and developing simpler and better ways for people with type 1 diabetes to measure, track and manage their diabetes. When Dexcom was established the only way to measure glucose levels was to fingerstick, it gave us a snapshot and not a story which made it difficult to understand our glucose levels and trends over time or feel in control of our diabetes. Since then, we’ve launched the world’s first real-time CGM system and helped to eliminate more than 11 billion fingersticks.
Learn more here: https://www.dexcom.com/en-gb
Empowered by 100 years of innovation, our mission at embecta is to develop and provide solutions that make life better for people living with diabetes. embecta is a leading producer of diabetes injection devices, manufacturing approximately 8 billion devices annually for an estimated 30 million PWD. Through its approximately 2,000 employees around the world, embecta is working to advance the standard of care in insulin delivery through strong community partnerships, innovative technology and comprehensive care resources.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod© 5 Automated Insulin Delivery system, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
Learn more here: https://www.omnipod.com/en-gb/hcp
Lilly is a medicine company turning science into therapies to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world’s most significant health challenges. We have been a global leader in diabetes since 1923, and are redefining diabetes and obesity care today. Through research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity.
To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/.
Menarini Diagnostics UK’s mission focuses on analysing and monitoring healthcare trends. Empowering us to deliver innovative and quality diagnostic solutions that enhance patient outcomes.Our goal is to revolutionise the diagnostics sector, driving improvements in UK healthcare systems to boost efficiency while maintaining high standards of quality and safety.
Learn more: https://menarini-diabetes.co.uk/
Nipro is a leading global healthcare company, established in 1954 with over 38,000 employees worldwide. Nipro is committed to simplifying diabetes management with easy-to-use products combining 99.33% accuracy along with Nipro’s leading Customer Service. Our 4SURE portfolio includes a blood glucose meter, combined blood glucose and β-ketone meter, we also provide blood glucose and ketone test strips, a wide range of insulin pen needles and access to remote monitoring and bolus advise app.
Learn more here: https://www.nipro-diagnostics.co.uk/patients
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.
To learn more, visit: https://www.novonordisk.co.uk/
Owen Mumford is at the forefront of medical device design and manufacturing, dedicated to improving lives through high-quality and sustainable healthcare solutions. With more than 70 years of expertise, we develop specialist devices for drug delivery, blood sampling and pelvic wellness, partnering with leading pharmaceutical and diagnostic companies across the globe. Our commitment to responsible innovation and strengthened sustainability practices supports better experiences for patients, clinicians and healthcare systems worldwide.
More at https://www.owenmumford.com/